| abstract |
Use of a compound according to formula (I) ** (See formula) ** or an isomer thereof, or a pharmaceutically acceptable salt thereof, or of a compound according to formula (II): ** (See formula) * * or an isomer thereof, or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for treating and / or preventing hypopigmentary disorders, in which the hypopigmentary disorder is selected from vitiligo and post-inflammatory hypopigmentation. |